Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy

Purpose of reviewIn recent years, major advances in molecular imaging of prostate cancers (PCa) were made with the development and clinical validation of highly accurate PET tracers to stage and restage the disease. Prostate-specific membrane antigen (PSMA) is a transmembrane protein highly expresse